Characteristics and mortality of severe influenza cases treated with parenteral aqueous zanamivir United Kingdom October 2009 to January 2011

摘要

BackgroundAqueous zanamivir solution, an investigational product, was provided by the manufacturer on compassionate grounds for parenteral administration to severe H1N1pdm09 influenza cases during the 2009 pandemic.